Navigation Links
Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
Date:5/19/2008

s, competitive offerings, product performance and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward- looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward- looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific Announces FDA Approval of New Heart Failure Lead
2. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
3. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
4. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
5. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
6. Fraunhofer and Boston University Hosted Prestigious SME Tour
7. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
8. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
9. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
10. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
11. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Eckert & ... Mass Spectrometry (AMS) services to the pharmaceutical and biotech ... joined the company in the position of Director of ... of broad and valuable experience in drug metabolism and ...
(Date:1/22/2015)... Cambridge Semantics, the leading provider of smart ... 2014 was a record-breaking year across the board for the ... Smart Data Platform and our Smart Data solutions, our customers ... data which led to record growth for the company in ...
(Date:1/22/2015)... Boston, MA (PRWEB) January 22, 2015 ... systems, is pleased to announce an exciting product from a ... of motion analysis solutions over the past 15 years, with ... industries. Most recently, their 3D IMU system (inertial measurement unit), ...
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Cambridge Semantics Announces Record Results for 2014 23D Motion Capture Just Got Easy 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... to Identify Host Correlates of Protection Against Tuberculosis , ... OTTAWA, ... of products for biological sample collection, stabilization and preparation, today ... South African Tuberculosis Vaccine Initiative (SATVI), has chosen Oragene-DNA for ...
... 28 Dendreon Corporation (Nasdaq: DNDN ) announced ... IMPACT study in the New England Journal of Medicine ... in overall survival compared to control in men with asymptomatic ... manuscript is published in the July 29, 2010 ...
... 28 Burrill & Company, a San Francisco -based global ... Banking and Media, is pleased to announce that Shawn Cross ... , , , ... the Merchant Banking Group,s strategic growth plan, which includes a broad and ...
Cached Biology Technology:DNA Genotek's Oragene-DNA Achieves 95% Compliance Rate in South African Tuberculosis Vaccine Initiative (SATVI) 2DNA Genotek's Oragene-DNA Achieves 95% Compliance Rate in South African Tuberculosis Vaccine Initiative (SATVI) 3New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 2New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 3New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 4New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 5New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 6Shawn Cross Appointed CEO of Burrill Merchant Banking Group 2Shawn Cross Appointed CEO of Burrill Merchant Banking Group 3
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ...
(Date:12/17/2014)... 16, 2014 Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... Chemical Sensor Market 2015-2019" report to their offering. ... One major trend upcoming in this market is the ... sensors help in recording of patient data for quick ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... A structural molecule and the cellular pump that regulates its ... ways of treating the lung infection, which is a leading ... University of Pittsburgh and the University of Iowa. Their findings ... Despite decades of research, there has been little new information ...
... key protein that regulates the biological clocks of mammals ... altering the levels of this protein can improve the ... this week,s advanced online publication of the journal ... for scientists to develop treatments for obesity and type ...
... Two researchers at Marshall University have been awarded ... the effects of omega-3 fatty acids on breast cancer ... Cancer Research Program has awarded Dr. Elaine Hardman, associate ... the Joan C. Edwards School of Medicine, and Dr. ...
Cached Biology News:Pitt/Iowa team finds cellular structural molecule can be toxic: Makes pneumonia worse 2Biologists discover biochemical link between biological clock and diabetes 2Biologists discover biochemical link between biological clock and diabetes 3Biologists discover biochemical link between biological clock and diabetes 4Marshall University researchers awarded more than $1 million for breast cancer studies 2Marshall University researchers awarded more than $1 million for breast cancer studies 3
... Workgroup solution is a highly scalable ... expression data in a workgroup or ... in over 40 leading pharmaceutical, biotechnology, ... GeneSpring Workgroup streamlines genomics research at ...
... for proteomic scale kinase profiling, quantitative ... drug discovery research built on the ... synthesis platform. These microarrays are available ... Kinase Substrate - Peptide Microarray Service. ...
... PEP-165 is an 18 amino acid synthetic peptide whose sequences ... peptide is (amino to carboxy terminus): S(21) - S - M ... D - E - A - I - D - K ... C(39). This peptide may be used for neutralization and ...
... containing peptidomimetics built on the flexible ... platform. These microarrays are available as ... Microarray Service. Custom Probe ... customer specified. Thousands of customer specified ...
Biology Products: